Parisi Samuel Joseph reported option exercise involving 12,825 derivative units of Alkermes plc. at $0.00 for $0 on May 29, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
VP, Finance (Interim PAO)
VP, Finance (Interim PAO)
Filed May 29, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
12,825Employee Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
12,826Direct
Trade date
May 29, 2026Option exercise
Filed
May 29, 2026, 6:03 PM ET0-day reporting delay
Accession
0001520262-26-000095Code M · Transaction 93345
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 29, 2026Option exercise3,392$20.03$67,941.76Trade 93341
May 29, 2026Option exercise12,825$19.34$248,035.50Trade 93342
May 29, 2026Option exercise3,392$0.00$0Trade 93344
May 29, 2026Sell16,217$42.36−$687,007.26Trade 93343
5 transaction rows in this filing. Joint filers share the same rows.

ALKS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ALKS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −20%1w ago −13%1d ago −5.3%
Returns since7d +1.4%30d +31%90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.245 to $42.50. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. F2: These options are fully vested in accordance with their terms.